NRX Pharmaceuticals Inc (NRXP) Stock Price

3.43 ▲ +0.16 (+4.89%)
Open: 3.10 Vol: 1.27M Day's range: 3.09 - 3.67 Aug 17, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
NRXP Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL BUY BUY BUY SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 3.49▼ 3.50▼ 3.50▼ 3.36▲ 3.44▼
MA10 3.51▼ 3.51▼ 3.40▲ 3.29▲ 3.72▼
MA20 3.51▼ 3.38▲ 3.36▲ 3.48▼ 3.50▼
MA50 3.51▼ 3.37▲ 3.42▲ 3.80▼ 2.84▲
MA100 3.40▲ 3.40▲ 3.28▲ 3.39▲ 2.59▲
MA200 3.37▲ 3.30▲ 3.71▼ 2.79▲ 3.98▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.010▼ 0.013▲ 0.024▲ 0.016▲ -0.080▼
RSI 35.057▼ 53.161▲ 53.820▲ 46.937▼ 52.149▲
STOCH 13.830▼ 51.717     72.112     37.919     35.375    
WILL %R -96.552▼ -45.098     -44.231     -54.125     -72.707    
CCI -187.895▼ 18.592     65.619     45.032     -78.949    
Latest Filters Detected On NRXP
MA $NRXP Price Crossed Above MA(7) Set Alert
▼ GAP $NRXP Open Gap Down %5 Set Alert
▼ GAP $NRXP Open Gap Down %3 Set Alert
▼ GAP $NRXP Open Gap Down %2 Set Alert
CDL $NRXP Three-Line Strike Candlestick Pattern Detected Set Alert
CDL $NRXP Engulfing Candlestick Pattern Detected Set Alert
NRX Pharmaceuticals Inc News
NRX Pharmaceuticals Inc Ordinary Shares NRXP
Thursday, August 13, 2026 05:00 PM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
NRx Pharmaceuticals Nears FDA Decision on Preservative-Free Ketamine After Review Clears Hurdles
Monday, August 10, 2026 07:05 AM
NRx Pharmaceuticals (NASDAQ:NRXP) said it has completed the first-cycle U.S. Food and Drug Administration review of its abbreviated new drug application, or ANDA, for preservative-free ketamine, with ...
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans
Friday, August 07, 2026 09:01 AM
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it will host a conference call and Q&A session on ...
NRXP historical stock data
date open high low close volume
17/08/26 3.10 3.67 3.09 3.43 1,265,211
14/08/26 3.37 3.40 3.155 3.27 1,128,895
13/08/26 3.41 3.63 3.315 3.34 1,238,582
12/08/26 3.40 3.50 3.29 3.36 927,898
11/08/26 3.39 3.64 3.35 3.40 1,166,960
10/08/26 3.51 3.64 3.31 3.35 1,996,331
07/08/26 3.50 4.1497 3.3706 3.58 5,676,501
06/08/26 3.06 3.18 3.03 3.09 552,115
05/08/26 3.02 3.11 2.90 3.055 685,891
04/08/26 3.30 3.32 2.94 3.05 1,256,699
Quote Details
52wk Low:1.62
52wk High:5.055
Vol:1.27M
Avg Vol(3m):21.6M
1Y Chng:+31.92%
1M Chng:-17.55%
Add to Watch List
More Information
Index US Composite
Market Cap. 139.96M